BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4332582)

  • 1. Antagonists of angiotensin. Substitution of an aliphatic chain to phenyl ring in position 8.
    Regoli D; Park WK; Rioux F; Chan CS
    Rev Can Biol; 1971 Dec; 30(4):319-29. PubMed ID: 4332582
    [No Abstract]   [Full Text] [Related]  

  • 2. Competitive antagonists of angiotensin II on the isolated rat stomach strip.
    Rioux F; Regoli D; Park WK
    Rev Can Biol; 1971 Dec; 30(4):333-6. PubMed ID: 4332583
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissociation constant of angiotensin II as determined by the use of an irreversible specific inhibitor (1-Sar-8-Leu-AT II ).
    Regoli D; Rioux F; Park WK
    Rev Can Biol; 1972 Mar; 31(1):73-7. PubMed ID: 4336058
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of angiotensin.
    Regoli D; Park WK; Rioux F
    Pharmacol Rev; 1974 Jun; 26(2):69-123. PubMed ID: 4371235
    [No Abstract]   [Full Text] [Related]  

  • 5. II. Pharmacology of angiotensin antagonists.
    Regoli D; Park WK; Rioux F
    Can J Physiol Pharmacol; 1973 Feb; 51(2):114-21. PubMed ID: 4348959
    [No Abstract]   [Full Text] [Related]  

  • 6. The pressor and myotropic effects and the antagonistic properties of several analogues of angiotensin II.
    Regoli D; Park WK
    Can J Physiol Pharmacol; 1972 Feb; 50(2):99-112. PubMed ID: 4336727
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemistry and mechanism of new angiotensin UU antagonists: 8 C-phenylclycine analogues of [5-isoleucine] angiotensin].
    Wissmann H; Schoelkens B; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1974 Sep; 355(9):1083-96. PubMed ID: 4376799
    [No Abstract]   [Full Text] [Related]  

  • 8. Further studies on lidoflazine (R-7904).
    Türker RK; Kayaalp SO; Ozer A
    Arzneimittelforschung; 1968 Sep; 18(9):1209-12. PubMed ID: 4387885
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of smooth muscle receptors for angiotensin: studies with an antagonist.
    Mimran A; Hinrichs KJ; Hollenberg NK
    Am J Physiol; 1974 Jan; 226(1):185-90. PubMed ID: 4358849
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of lidoflazine on norepinephrine, angiotensin and serotonin responses in isolated smooth muscle preparations.
    Türker RK; Kayaalp SO
    Experientia; 1967 Aug; 23(8):647. PubMed ID: 4293123
    [No Abstract]   [Full Text] [Related]  

  • 11. A potent competitive antagonist of angiotensin II.
    Yamamoto M; Türker RK; Khairallah PA; Bumpus FM
    Eur J Pharmacol; 1972 May; 18(3):316-22. PubMed ID: 4338477
    [No Abstract]   [Full Text] [Related]  

  • 12. Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Nov; 17(11):1156-60. PubMed ID: 4369767
    [No Abstract]   [Full Text] [Related]  

  • 13. 1,8-disubstituted analogues of (Ile5) and (Val5)angiotensin II: difference in potency and specificity of angiotensin II-antagonistic activity.
    Schoelkens BA; Wissmann H; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1976 Jun; 357(6):825-38. PubMed ID: 955577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the N-terminal amino acid for the biological activities of angiotensin and inhibitory analogues.
    Regoli D; Rioux F; Park WK; Choi C
    Can J Physiol Pharmacol; 1974 Feb; 52(1):39-49. PubMed ID: 4363494
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis of [1-sarcosine, 8-O-methylserine]angiotensin II and 1-substituted analogues of [8-threonine]angiotensin II as antagonists of angiotensin II.
    Khosla MC; Hall MM; Munoz-Ramírez H; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Feb; 20(2):253-6. PubMed ID: 836496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some aspects of the pharmacology of valyl-beta-(pyrazolyl-3)-L-alanyl6-angiotensin II.
    Hageman WE; Hofmann K; Ertel RJ; Buckley JP
    J Pharmacol Exp Ther; 1969 Aug; 168(2):295-302. PubMed ID: 4308499
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of some analogs of angiotensin II as specific antagonists of the parent hormone.
    Khosla MC; Leese RA; Maloy WL; Ferreira AT; Smeby RR; Bumpus FM
    J Med Chem; 1972 Aug; 15(8):792-5. PubMed ID: 4339769
    [No Abstract]   [Full Text] [Related]  

  • 18. A new class of angiotensin inhibitors: N-methylphenylalanine analogs.
    Peña C; Stewart JM; Goodfriend TC
    Life Sci; 1974 Apr; 14(7):1331-6. PubMed ID: 4363010
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific antagonists for the myotropic action of angiotensin II and angiotensin I on the isolated rat colon.
    Gagnon D; Park WK; Regoli D
    Br J Pharmacol; 1971 Oct; 43(2):409-10. PubMed ID: 4333805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of angiotensin II antagonists by incorporating alpha-methylalanine or O-methylthreonine residues in angiotension II analogues.
    Khosla MC; Muñoz-Ramírez H; Hall MM; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Aug; 20(8):1051-5. PubMed ID: 894674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.